Form 4: CME Group Executive Derek Sammann Reports Stock Transactions

Derek Sammann, a Senior Managing Director at CME Group, reports the acquisition and disposal of company stock related to a performance share award.

Summary

• On March 15, 2024, Derek Sammann, a Senior Managing Director at CME Group, reported transactions involving CME Group Class A Common Stock.
• He acquired 6,803 shares at a price of $217.5 per share related to a 2020 performance share award.
• Mr. Sammann also disposed of 3,014 shares at $217.5 per share to cover tax withholding obligations.
• Following these transactions, Mr. Sammann directly owns 13,483 shares and indirectly owns 12,239 shares via a trust and 7,022 shares via a spouse.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the filing primarily reports routine stock transactions related to executive compensation. The vesting of performance shares is a positive sign, but the tax-related disposal is a standard procedure.

Positives

• The acquisition of shares indicates that the company met its performance targets related to total shareholder return relative to the S&P 500 over the period 2021-2023.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies like CME Group.

Comparison to Industry Standards

• Executive compensation packages often include performance-based equity awards to align management's interests with those of shareholders.
• The vesting of performance shares based on total shareholder return relative to the S&P 500 is a common metric used by companies to incentivize long-term value creation.
• Similar to executives at Intercontinental Exchange (ICE) and Nasdaq (NDAQ), CME Group executives receive equity compensation as part of their overall remuneration.

Stakeholder Impact

• The vesting of performance shares suggests that the company has met certain performance criteria, which is generally positive for shareholders.

Key Dates